with a market cap of around $17m it has great blue sky potential.I thought the following was also very impressive as secondary outcome measure especially given millions die each year from malaria
"Complete cure (crude and PCR (polymerase chain reaction) adjusted) [ Time Frame: 28 days after the start of treatment ] [ Designated as safety issue: No ] The complete resolution of clinical signs and symptoms, malaria-related laboratory abnormalities, and elimination of asexual parasites by Day 7, with no recurrence up to Day 28 (+/- 2 days), and the 48h parasite count to be < 25% of baseline with no clinical deterioration"
EMS Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
